Financial Highlights

Consolidated Income Statement

Figures in THBmn

  2015 2016 2017
Operating Revenue 7,945 8,810 9,597
Gross profit 3,406 3,687 4,320
Selling and Admin. Exp (SGA) 2,660 2,674 2,965
SGA (% to revenue) 33.5% 30.4% 30.9%
EBITDA 986 1,107 1,479
EBITDA (% to revenue) 12.4% 12.6% 15.4%
EBIT 841 955 1,324
Net Profit 696 795 1,113
Net profit (% to revenue) 8.8% 9.0% 11.6%
EPS (THB) 0.80 0.92 1.29
Return on equity 16.7% 17.6% 22.4%
Net cash from operations 609 1,250 927
Cash cycle (days) 129 121 123


Revenue by segments (THBmn)

  2015 2016 2017
Mega We CareTM Business 3,907 4,251 5,078
MaxxcareTM Business 3,558 4,160 4,053
OEM 480 399 467


Consolidated Balance Sheet

All figures in THBmn

  Dec’15 Dec’16 Dec’17
Cash and bank balances1 1,467 1,217 1,174
Trade accounts receivable 2,263 2,233 2,520
Inventories 2,067 1,889 2,219
Property, plant and equipment 1,031 1,152 1,221
Intangible asset2 233 736 734
Other Assets 549 702 852
Total Assets 7,610 7,941 8,720
Debt 719 670 512
Trade Payables 1,603 1,519 1,598
Other Liabilityies 954 1,073 1,365
Total Outside Liabilities 3,275 3,261 3,475
Shareholder Equity 4,335 4,680 5,244
Total Liabilities and Equity 7,610 7,941 8,720


Key Balance Sheet elements

  Dec’15 Dec’16 Dec’17
Net cash/(debt) (THBmn) 748 547 662
Capex spent3 (THBmn) 181 1,016 270
IBD/Equity (times) (0.17) (0.12) (0.13)

1 Cash and Bank balances as at blances sheet dates include non-restricted term deposits with banks.
2 Intangible asstes as at Dec’17 includes THB 220mn to goodwill arising from acquistion of Bio-Life Marketing Sdn. Bhd.
3 Capex spent means cash outflow on investment in property plant and equipments and business acqusitions. 2017 spending includes THB 592mn towards acqustion of Bio-Life Marketing Sdn. Bhd. (Malaysia).